JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 116 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,975,000 | -70.4% | 981,928 | -33.7% | 0.25% | -67.5% |
| Q1 2022 | $10,057,000 | -23.9% | 1,481,219 | -6.4% | 0.76% | -1.2% |
| Q4 2021 | $13,216,000 | +179.1% | 1,582,777 | +148.3% | 0.77% | +175.7% |
| Q3 2021 | $4,735,000 | +11.5% | 637,347 | +2.0% | 0.28% | +14.3% |
| Q2 2021 | $4,248,000 | -19.2% | 624,756 | +22.1% | 0.24% | -22.5% |
| Q1 2021 | $5,256,000 | -18.9% | 511,822 | -44.7% | 0.32% | -18.1% |
| Q4 2020 | $6,477,000 | – | 925,280 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,347,829 | $9,152,000 | 93.42% |
| Ally Bridge Group (NY) LLC | 550,000 | $3,735,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 813,500 | $5,524,000 | 2.58% |
| TRV GP III, LLC | 1,148,780 | $7,800,000 | 2.12% |
| Deep Track Capital, LP | 4,259,653 | $28,923,000 | 1.86% |
| Logos Global Management LP | 1,400,000 | $9,506,000 | 1.23% |
| PFM Health Sciences, LP | 3,972,868 | $26,976,000 | 1.01% |
| Sofinnova Investments, Inc. | 1,481,219 | $10,057,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 248,347 | $1,686,000 | 0.70% |
| RTW INVESTMENTS, LP | 4,680,412 | $31,780,000 | 0.66% |